Proteomics Market

Proteomics Market by Product (Spectroscopy, Chromatography, Electrophoresis, X-ray Crystallography), Reagent, Service (Core Proteomics, Bioinformatics), Application (Diagnostic, Drug Discovery), End User (Hospital, Labs, Biopharma) - Global Forecast to 2026

Report Code: BT 2341 Mar, 2021, by marketsandmarkets.com

[296 Pages Report] The global proteomics market is projected to reach USD 55.9 billion by 2026 from USD 25.9 billion in 2021, at a CAGR of 16.6% during the forecast period. An increase in the research activity, especially in the area of personalized medicine and drug discovery, is the primary growth driver for this market. In addition, the increasing R&D expenditure by pharmaceutical and biotechnology companies, increasing government funding, and technological advancements are also propelling the market growth.

Proteomics Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on Global Proteomics market

The COVID-19 outbreak is an unprecedented global public health challenge and is expected to have a significant impact on the proteomics market, as researchers across the globe are focusing on decoding three-dimensional structures of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins. Scientists are also trying to study the identification methods, structures, characterization, and interactions of these proteins to develop effective drugs and biological products against COVID-19. To identify a new effective target therapeutic drug for a virus, it is important to understand the protein structure of virus proteins and their specific sites. At this stage, protein crystallization techniques play an important role as they provide high-resolution 3D structures.

Market Dynamics

Driver: Rising prevalence of cancer and associated genetic disorders

In the past decade, several significant discoveries were made in the field of life sciences, completion of the sequencing of the human genome being one of them. The next significant biomedicine milestone was the characterization of human protein, which is a relatively new and extremely dynamic branch of science focused on the evaluation of gene expression at the proteome level. With limited research performed in proteomics to date, current proteomics is limited to deal with several issues such as protein identification, quantification, characterization of post-translational modification, structure and function elucidation, and description of possible interactions. However, with increasing research efforts, both monetary and technical, the field of proteomics is expected to incorporate technologies that can be applied to serum and tissue samples in order to extract important biological information in the form of biomarkers to aid clinicians and scientists in understanding the dynamic biology of their system of interest, such as patients with cancer.

Opportunity: Increasing prominence of nanoproteomics

The field of nanotechnology has been associated with several proteomics applications such as phosphoproteomics/metal oxide nanoparticles, nanostructured surfaces for protein separation, and analytical detection of biomarker proteins using array techniques. This has led to the emergence of nanoproteomics, a science involving the application of proteomics techniques aided by nanotechnology. This technique is utilized as a complementary component to revolutionize proteomics through different kinds of nanotechnology applications, including nanoporous structures, functionalized nanoparticles, quantum dots, and polymeric nanostructures.

Challenges: High cost of instruments

Companies rely on accessible structural data and trial-and-error methods to determine the compounds that either stimulate or disable target proteins. The structuring of proteins involves the use of rapid, high-throughput tools and machines. X-ray crystallography is one of the most widely used methods in proteomics, which conducts gene cloning, protein expression, and purification and crystallization of proteins. All these processes need a large number of laboratory hours, increasing the per sample testing costs. Such high prices of instruments and reagents make it difficult for developing countries to venture into the field of proteomics.

Immunoassay reagents segment accounted for the largest share of the proteomics market, by reagents, in 2020

The proteomics market, by reagent, is segmented into protein microarray reagents, spectroscopy reagents, X-ray crystallography reagents, chromatography reagents, electrophoresis reagents, immunoassay reagents, and protein fractionation reagents. In 2020, the immunoassay reagents segment accounted for the largest share of the proteomics market. The large share of this segment can be attributed to the availability of a wide range of reagents and the need for reliable, specific, and fast detection of diseases at the early stages.

Pharmaceutical companies segment accounted for the largest share in the market, by end user, in 2020

Based on end users, the proteomics market is segmented into hospitals, clinical laboratories, pharmaceutical companies, academic research laboratories, and other end users. In 2020, the pharmaceutical companies segment accounted for the largest market share of the proteomics market. The large share of this segment can be attributed to the increasing research funding for genomics and proteomics research and the increasing outsourcing of research activities to various pharmaceutical companies with in-house CRO services.

North America is the largest regional market for proteomics market

The global proteomics market is segmented into North America, Europe, the Asia Pacific, Latin America and Middle East & Africa. In 2020, North America accounted for the largest market share in the proteomics market. This can be attributed to the increasing investments in the development of structure-based drug design, growing research in the field of omics, rising demand for high-quality research tools for data reproducibility, and increasing focus on developing personalized therapeutics. The presence of a large number of global players in this region is also supporting the growth of this market.

Proteomics Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Some key players in the proteomics market (2021 - 2026)

The major players operating in this market are Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Bruker Corporation (US), Danaher Corporation (US), GE Healthcare (US), Luminex Corporation (US), PerkinElmer Inc. (US), Waters Corporation (US), Illumina, Inc. (US), Eurofins Scientific (Luxembourg), QIAGEN Bioinformatics (Netherlands), Creative Proteomics (US), Promega Corporation (US), Sengenics (Singapore), Biomax Informatics AG (Germany), MS Bioworks LLC (US), WuXi NextCODE (China), Fios Genomics Ltd. (UK), GENEWIZ (US), Biognosys AG (Switzerland), Bioproximity (Switzerland), MRM Proteomics Inc. (Canada), Integrated Proteomics Applications (US), Poochon Scientific, LLC (US), Proteome Factory AG (Germany), VProteomics (India), HORIBA, Ltd. (Japan), and Applied Biomics, Inc. (US).

Scope of the Report

Report Metric

Details

Market size available for years

2019–2026

Base year considered

2020

Forecast period

2021–2026

Forecast units

Value (USD Billion)

Segments covered

Instrumentation technology, reagent, software & service, application, end user, and region

Geographies covered

North America, Europe, Asia Pacific, Latin America, & Middle East & Africa

Companies covered

Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Bruker Corporation (US), Danaher Corporation (US), GE Healthcare (US), Luminex Corporation (US), PerkinElmer Inc. (US), Waters Corporation (US), Illumina, Inc. (US), Eurofins Scientific (Luxembourg), QIAGEN Bioinformatics (Netherlands), Creative Proteomics (US), Promega Corporation (US), Sengenics (Singapore), Biomax Informatics AG (Germany), MS Bioworks LLC (US), WuXi NextCODE (China), Fios Genomics Ltd. (UK), GENEWIZ (US), Biognosys AG (Switzerland), Bioproximity (Switzerland), MRM Proteomics Inc. (Canada), Integrated Proteomics Applications (US), Poochon Scientific, LLC (US), Proteome Factory AG (Germany), VProteomics (India), HORIBA, Ltd. (Japan), and Applied Biomics, Inc. (US).

This report categorizes the proteomics market into the following segments and subsegments:

By Instrumentation Technology

  • Spectroscopy
    • Mass Spectroscopy
    • NMR Spectroscopy
    • CD Spectroscopy
  • Chromatography
    • HPLC
    • Ion Chromatography
    • Affinity Chromatography
    • Supercritical Fluid Chromatography
  • Electrophoresis
    • Gel Electrophoresis
    • Capillary Electrophoresis
  • Protein Microarrays
    • Biochips
      • Lab-on-Chips
      • Protein Chips
    • Micrparray Instruments
      • Integrated Systems
      • Microarray Scanners
      • Arrayers
  • X – Ray Crystallography
  • Surface Plasmon Resonance
  • Protein Fractionation

By Reagent

  • Immunoassay Reagents
  • Spectroscopy Reagents
  • Chromatography Reagents
  • Protein Microarray Reagents
  • X – Ray Crystallography Reagents
  • Electrophoresis Reagents
  • Protein Fractionation Reagents

By Software & Service

  • Core Proteomics Services
    • Protein Identification Services
    • Protein Characterization Services
    • Quantitative Proteomic Services
    • Protein Purification Services
    • Protein Sequencing Services
    • Custom Assay Services
  • Bioinformatics Software & Services
    • Bioinformatics Software
    • Bioinformatics Tools
    • Bioinformatics Databases

By Application

  • Clinical Diagnostics
    • Cancer
    • Infectious Diseases
    • Diabetes
    • Neurological Disorders
    • Immune Diseases
    • Cardiovascular Diseases
    • Other Clinical Diagnostic Applications
  • Drug Discovery
    • Target Discovery
    • Lead Identification
    • Lead Optimization
    • Preclinical Studies
  • Other Application

By End User

  • Hospitals
  • Clinical Laboratories
  • Pharmaceutical Companies
  • Academic Research Laboratories
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Switzerland
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • Australia
    • India
    • Rest of Asia Pacific 
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

Recent Developments

  • In 2021, Thermo Fisher Scinetific (US) acquired Phitonex (US).
  • In 2020, Perkin Elmer (US) launched SARS-COV-2 Antigen Elisa Test.
  • In 2020, Bruker Corporation (US) acquired Integrated Proteomics Applications’ IP2 software.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 32)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
        FIGURE 1 INCLUSIONS & EXCLUSIONS OF THE STUDY
           1.2.1 MARKETS COVERED
                 FIGURE 2 PROTEOMICS MARKET SEGMENTATION
           1.2.2 YEARS CONSIDERED FOR THE STUDY
    1.3 CURRENCY
    1.4 STAKEHOLDERS
    1.5 LIMITATIONS
    1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 37)
    2.1 RESEARCH DATA
        FIGURE 3 RESEARCH DESIGN
           2.1.1 SECONDARY RESEARCH
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION
           2.2.1 BOTTOM-UP APPROACH
                 FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION
                 FIGURE 6 BOTTOM-UP APPROACH: SEGMENTAL REVENUE ESTIMATION
           2.2.2 TOP-DOWN APPROACH
                 FIGURE 7 PROTEOMICS MARKET: TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN & DATA TRIANGULATION
        FIGURE 8 DATA TRIANGULATION METHODOLOGY
    2.4 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. - 45)
  FIGURE 9 PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021 VS. 2026 (USD MILLION)
  FIGURE 10 PROTEOMICS MARKET, BY REAGENT, 2021 VS. 2026 (USD MILLION)
  FIGURE 11 PROTEOMICS MARKET, BY SERVICE & SOFTWARE, 2021 VS. 2026 (USD MILLION)
  FIGURE 12 PROTEOMICS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
  FIGURE 13 PROTEOMICS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
  FIGURE 14 PROTEOMICS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)

4 PREMIUM INSIGHTS (Page No. - 49)
    4.1 PROTEOMICS MARKET OVERVIEW
        FIGURE 15 INCREASING DEMAND FOR PERSONALIZED MEDICINE TO DRIVE MARKET GROWTH
    4.2 SPECTROSCOPY MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
        FIGURE 16 MASS SPECTROSCOPY SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2026
    4.3 ELECTROPHORESIS MARKET SHARE, BY TYPE, 2021 VS. 2026
        FIGURE 17 GEL ELECTROPHORESIS SEGMENT WILL ACCOUNT FOR THE LARGEST MARKET SHARE IN 2021
    4.4 PROTEOMICS MARKET, BY REGION (2021−2026)
        FIGURE 18 ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 52)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
        FIGURE 19 PROTEOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 MARKET DRIVERS
                    5.2.1.1 Increasing demand for personalized medicine
                            FIGURE 20 NUMBER OF PERSONALIZED MEDICINES IN THE MARKET, 2008–2020
                    5.2.1.2 Rising prevalence of cancer and associated genetic disorders
                            TABLE 1 CANCER INCIDENCE AND MORTALITY, BY REGION, 2012–2035
                    5.2.1.3 Proteomics bridges the gap between genomics and biochemistry
                    5.2.1.4 Increasing pharmaceutical and biotechnology R&D expenditure
                            FIGURE 21 R&D EXPENDITURE BY PHRMA MEMBER COMPANIES, 2001–2019 (USD BILLION)
                            TABLE 2 PHARMACEUTICAL R&D SPENDING, BY COMPANY, 2018
                            TABLE 3 FUNDING FOR NIH INNOVATION PROJECTS UNDER THE 21ST CENTURY CURES ACT, 2017–2026
                    5.2.1.5 Technological advancements
           5.2.2 MARKET RESTRAINTS
                    5.2.2.1 High cost of instruments
           5.2.3 MARKET OPPORTUNITIES
                    5.2.3.1 Growing prominence of nanoproteomics
                    5.2.3.2 Development of personalized proteomics for precision health
                    5.2.3.3 High growth opportunities in emerging countries
           5.2.4 MARKET CHALLENGES
                    5.2.4.1 Data management in proteomics research
                    5.2.4.2 Low biomarker discovery-to-approval ratio
    5.3 IMPACT OF COVID-19 ON THE PROTEOMICS MARKET
    5.4 PATENT ANALYSIS
        FIGURE 22 PROTEOMICS MARKET: PATENT ANALYSIS
    5.5 ECOSYSTEM ANALYSIS
    5.6 VALUE CHAIN ANALYSIS
        FIGURE 23 PROTEOMICS MARKET: VALUE CHAIN ANALYSIS
           5.6.1 PROTEOMICS MARKET: VALUE CHAIN ANALYSIS, BY ORGANIZATION
           5.6.2 PROTEOMICS MARKET: VALUE CHAIN ANALYSIS, BY MAJOR SPECIALIZATION
    5.7 SUPPLY CHAIN ANALYSIS
        FIGURE 24 PROTEOMICS MARKET: SUPPLY CHAIN ANALYSIS
    5.8 PORTER’S FIVE FORCES ANALYSIS
        FIGURE 25 PROTEOMICS MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.8.1 THREAT OF NEW ENTRANTS
           5.8.2 THREAT OF SUBSTITUTES
           5.8.3 BARGAINING POWER OF BUYERS
           5.8.4 BARGAINING POWER OF SUPPLIERS
           5.8.5 INTENSITY OF COMPETITIVE RIVALRY
    5.9 PESTEL ANALYSIS
        FIGURE 26 PROTEOMICS MARKET: PESTEL ANALYSIS
    5.10 TRADE ANALYSIS
           5.10.1 TRADE ANALYSIS FOR ELECTROPHORESIS & CHROMATOGRAPHY INSTRUMENTS
                  TABLE 4 IMPORT DATA FOR ELECTROPHORESIS AND CHROMATOGRAPHY INSTRUMENTS, BY COUNTRY, 2016-2020 (USD MILLION)
           5.10.2 TRADE ANALYSIS FOR SPECTROSCOPY INSTRUMENTS
                  TABLE 5 IMPORT DATA FOR SPECTROSCOPY INSTRUMENTS, BY COUNTRY, 2016-2020 (USD MILLION)
    5.11 REGULATORY GUIDELINES
           5.11.1 NORTH AMERICA
           5.11.2 EUROPE
           5.11.3 EMERGING MARKETS

6 PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY (Page No. - 72)
    6.1 INTRODUCTION
           6.1.1 PRICING ANALYSIS
                 TABLE 6 AVERAGE SELLING PRICES OF PRODUCTS AND SERVICES, 2021 (USD)
                 TABLE 7 PROTEOMICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                 TABLE 8 PROTEOMICS INSTRUMENTATION TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION)
                 TABLE 9 PROTEOMICS INSTRUMENTATION TECHNOLOGY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.2 SPECTROSCOPY
        TABLE 10 SPECTROSCOPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
        TABLE 11 SPECTROSCOPY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.2.1 MASS SPECTROSCOPY
                    6.2.1.1 The ability of MS to identify small amounts of protein from increasingly complex mixtures is a major factor driving its use in proteomics
                            TABLE 12 MASS SPECTROSCOPY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.2.2 NMR SPECTROSCOPY
                    6.2.2.1 NMR experiments are used to evaluate the physical, chemical, electronic, and structural information of proteins
                            TABLE 13 NMR SPECTROSCOPY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.2.3 CD SPECTROSCOPY
                    6.2.3.1 CD spectroscopy is used to examine changes in secondary structures of proteins in response to environmental conditions
                            TABLE 14 CD SPECTROSCOPY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.3 CHROMATOGRAPHY
        TABLE 15 CHROMATOGRAPHY MARKET, BY TYPE, 2019–2026 (USD MILLION)
        TABLE 16 CHROMATOGRAPHY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.3.1 HPLC
                    6.3.1.1 The two types of HPLC systems commonly available in the market are split-flow systems and non-split-flow systems
                            TABLE 17 HPLC MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.3.2 ION CHROMATOGRAPHY
                    6.3.2.1 Ion chromatography is the most commonly used chromatographic method for separating proteins
                            TABLE 18 ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.3.3 AFFINITY CHROMATOGRAPHY
                    6.3.3.1 Affinity chromatography is used for the isolation of proteins based on the interaction between target proteins and specific immobilized ligands
                            TABLE 19 AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.3.4 SUPERCRITICAL FLUID CHROMATOGRAPHY
                    6.3.4.1 SFC is used for the separation and analysis of integral membrane proteins and hydrophobic peptides
                            TABLE 20 SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.4 ELECTROPHORESIS
        TABLE 21 ELECTROPHORESIS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        TABLE 22 ELECTROPHORESIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.4.1 GEL ELECTROPHORESIS
                    6.4.1.1 The most common use of gel electrophoresis is the qualitative analysis of a complex mixture of proteins
                            TABLE 23 GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.4.2 CAPILLARY ELECTROPHORESIS
                    6.4.2.1 CE coupled with MS is used to assess the structure and identity of individual proteins
                            TABLE 24 CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.5 PROTEIN MICROARRAYS
        TABLE 25 PROTEIN MICROARRAYS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        TABLE 26 PROTEIN MICROARRAYS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.5.1 BIOCHIPS
                 TABLE 27 BIOCHIPS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                 TABLE 28 BIOCHIPS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.5.1.1 Lab-on-chips
                               6.5.1.1.1 LOC is one of the fastest-growing areas of microfabrication and nanotechnology development
                                         TABLE 29 LAB-ON-CHIPS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.5.1.2 Protein chips
                               6.5.1.2.1 Protein chips are used to study protein interactions
                                         TABLE 30 PROTEIN CHIPS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.5.2 MICROARRAY INSTRUMENTS
                 TABLE 31 MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                 TABLE 32 MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.5.2.1 Integrated systems
                               6.5.2.1.1 Integrated systems can carry out the entire procedure of protein analysis without any intermediate steps
                                         TABLE 33 INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.5.2.2 Microarray scanners
                               6.5.2.2.1 Microarray scanners find applications in the data analysis of proteins, tissues, and cells
                                         TABLE 34 MICROARRAY SCANNERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.5.2.3 Arrayers
                               6.5.2.3.1 Technological advancements have made microarray spotters ideal for large-scale arraying projects
                                         TABLE 35 ARRAYERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.6 X-RAY CRYSTALLOGRAPHY
           6.6.1 X-RAY CRYSTALLOGRAPHY HELPS IN THE MEASUREMENT OF THE 3D DENSITY DISTRIBUTION OF ELECTRONS IN A CRYSTALLIZED PROTEIN
                 TABLE 36 X-RAY CRYSTALLOGRAPHY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.7 SURFACE PLASMON RESONANCE
           6.7.1 SPR IMAGING HELPS MONITOR A RANGE OF MOLECULAR INTERACTIONS
                 TABLE 37 SURFACE PLASMON RESONANCE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.8 PROTEIN FRACTIONATION
           6.8.1 PROTEIN FRACTIONATION ENABLES THE EFFECTIVE SEPARATION OF THOUSANDS OF PROTEINS IN A COMPLEX MIXTURE
                 TABLE 38 PROTEIN FRACTIONATION MARKET, BY COUNTRY, 2019–2026 (USD MILLION)

7 PROTEOMICS MARKET, BY REAGENT (Page No. - 106)
    7.1 INTRODUCTION
        TABLE 39 PROTEOMICS REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        TABLE 40 PROTEOMICS REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    7.2 IMMUNOASSAY REAGENTS
           7.2.1 IMMUNOASSAY REAGENTS TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
                 TABLE 41 PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2019–2026 (USD MILLION)
    7.3 SPECTROSCOPY REAGENTS
           7.3.1 THE USE OF THESE REAGENTS IS INCREASING WITH THE RISING ADOPTION OF MS TECHNIQUES
                 TABLE 42 PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2019–2026 (USD MILLION)
    7.4 CHROMATOGRAPHY REAGENTS
           7.4.1 INCREASING DEMAND FOR PROTEIN PURIFICATION IS EXPECTED TO DRIVE MARKET GROWTH
                 TABLE 43 PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2019–2026 (USD MILLION)
    7.5 PROTEIN MICROARRAY REAGENTS
           7.5.1 THE USE OF THESE REAGENTS HAS INCREASED FOR ANALYZING PROTEIN INTERACTIONS
                 TABLE 44 PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2019–2026 (USD MILLION)
    7.6 X-RAY CRYSTALLOGRAPHY REAGENTS
           7.6.1 X-RAY CRYSTALLOGRAPHY PLAYS AN IMPORTANT ROLE IN PROTEIN STRUCTURE DETERMINATION
                 TABLE 45 PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2019–2026 (USD MILLION)
    7.7 ELECTROPHORESIS REAGENTS
           7.7.1 INCREASING DEMAND FOR 2D ELECTROPHORESIS IS DRIVING THE ADOPTION OF THESE REAGENTS
                 TABLE 46 PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2019–2026 (USD MILLION)
    7.8 PROTEIN FRACTIONATION REAGENTS
           7.8.1 INCREASING NEED FOR PROTEIN SEPARATION FROM COMPLEX MIXTURES IS DRIVING THE GROWTH OF THIS SEGMENT
                 TABLE 47 PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2019–2026 (USD MILLION)

8 PROTEOMICS MARKET, BY SERVICE & SOFTWARE (Page No. - 116)
    8.1 INTRODUCTION
        TABLE 48 PROTEOMICS SERVICES & SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION)
        TABLE 49 PROTEOMICS SERVICES & SOFTWARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    8.2 CORE PROTEOMICS SERVICES
        TABLE 50 CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
        TABLE 51 CORE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           8.2.1 PROTEIN IDENTIFICATION SERVICES
                    8.2.1.1 Protein identification services dominate the market
                            TABLE 52 PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           8.2.2 PROTEIN CHARACTERIZATION SERVICES
                    8.2.2.1 Characterization studies play a vital role in studying complex protein structure, drug development, and PTMs
                            TABLE 53 PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2019 - 2026 (USD MILLION)
           8.2.3 QUANTITATIVE PROTEOMICS SERVICES
                    8.2.3.1 Quantitative proteomics is critical for understanding protein expression and modifications
                            TABLE 54 QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           8.2.4 PROTEIN PURIFICATION SERVICES
                    8.2.4.1 Protein purification aids in improving the overall proteome analysis
                            TABLE 55 PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           8.2.5 PROTEIN SEPARATION SERVICES
                    8.2.5.1 Separation plays an important role in the characterization of large-sized proteomes
                            TABLE 56 PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           8.2.6 PROTEIN SEQUENCING SERVICES
                    8.2.6.1 Identification and characterization of PTMs is an important area of research that needs protein sequencing
                            TABLE 57 PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           8.2.7 CUSTOM ASSAY SERVICES
                    8.2.7.1 Custom assays are adopted to improve the validation or consistency of the protein analysis procedures
                            TABLE 58 CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    8.3 BIOINFORMATICS SOFTWARE & SERVICES
        TABLE 59 BIOINFORMATICS SOFTWARE & SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
        TABLE 60 BIOINFORMATICS SOFTWARE & SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           8.3.1 BIOINFORMATICS SERVICES
                    8.3.1.1 Bioinformatics services will dominate the market in the forecast period
                            TABLE 61 BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           8.3.2 BIOINFORMATICS TOOLS
                    8.3.2.1 Need for data management makes bioinformatics tools an imperative part of proteomics
                            TABLE 62 BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           8.3.3 BIOINFORMATICS DATABASES
                    8.3.3.1 Databases majorly contribute to storing proteomics data along with integrating other omics databases
                            TABLE 63 BIOINFORMATICS DATABASES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)

9 PROTEOMICS MARKET, BY APPLICATION (Page No. - 136)
    9.1 INTRODUCTION
        TABLE 64 PROTEOMICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
    9.2 CLINICAL DIAGNOSTICS
        TABLE 65 PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)
        TABLE 66 PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
           9.2.1 CANCER
                    9.2.1.1 Increasing number of research studies in cancer therapeutics to drive the market growth
                            TABLE 67 CLINICAL DIAGNOSTICS MARKET FOR CANCER, BY COUNTRY, 2019–2026 (USD MILLION)
           9.2.2 INFECTIOUS DISEASES
                    9.2.2.1 Increasing prevalence of infectious diseases to drive the market growth
                            TABLE 68 CLINICAL DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)
           9.2.3 DIABETES
                    9.2.3.1 High burden of diabetes to propel market growth
                            TABLE 69 CLINICAL DIAGNOSTICS MARKET FOR DIABETES, BY COUNTRY, 2019–2026 (USD MILLION)
           9.2.4 NEUROLOGICAL DISORDERS
                    9.2.4.1 Rising prevalence of neurological disorders to support market growth
                            TABLE 70 CLINICAL DIAGNOSTICS MARKET FOR NEUROLOGICAL DISORDERS, BY COUNTRY, 2019–2026 (USD MILLION)
           9.2.5 AUTOIMMUNE DISEASES
                    9.2.5.1 Increasing prevalence of autoimmune diseases to drive the market growth
                            TABLE 71 CLINICAL DIAGNOSTICS MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)
           9.2.6 CARDIOVASCULAR DISEASES
                    9.2.6.1 High burden of CVD has increased the focus on developing reliable diagnostic tools
                            TABLE 72 CLINICAL DIAGNOSTICS MARKET FOR CVD, BY COUNTRY, 2019–2026 (USD MILLION)
           9.2.7 OTHER CLINICAL DIAGNOSTIC APPLICATIONS
                 TABLE 73 OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    9.3 DRUG DISCOVERY
        TABLE 74 PROTEOMICS MARKET FOR DRUG DISCOVERY, BY TYPE, 2019–2026 (USD MILLION)
        TABLE 75 PROTEOMICS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2019–2026 (USD MILLION)
           9.3.1 TARGET DISCOVERY
                    9.3.1.1 Increasing demand for personalized medicine to support the growth of this market
                            TABLE 76 DRUG DISCOVERY MARKET FOR TARGET DISCOVERY, BY COUNTRY, 2019–2026 (USD MILLION)
           9.3.2 LEAD IDENTIFICATION
                    9.3.2.1 Lead identification is the most revenue-generating process
                            TABLE 77 DRUG DISCOVERY MARKET FOR LEAD IDENTIFICATION, BY COUNTRY, 2019–2026 (USD MILLION)
           9.3.3 LEAD OPTIMIZATION
                    9.3.3.1 Lead optimization requires state-of-the-art informatics systems to facilitate transparent presentation and analysis
                            TABLE 78 DRUG DISCOVERY MARKET FOR LEAD OPTIMIZATION, BY COUNTRY, 2019–2026 (USD MILLION)
           9.3.4 PRECLINICAL STUDIES
                    9.3.4.1 FDA requires researchers to use GLP during preclinical studies
                            TABLE 79 DRUG DISCOVERY MARKET FOR PRECLINICAL STUDIES, BY COUNTRY, 2019–2026 (USD MILLION)
    9.4 OTHER APPLICATIONS
        TABLE 80 DRUG DISCOVERY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)

10 PROTEOMICS MARKET, BY END USER (Page No. - 154)
     10.1 INTRODUCTION
          TABLE 81 PROTEOMICS MARKET, BY END USER, 2019–2026 (USD MILLION)
     10.2 PHARMACEUTICAL COMPANIES
             10.2.1 RISING FOCUS ON DRUG DISCOVERY TO DRIVE MARKET GROWTH
                    TABLE 82 PROTEOMICS MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
     10.3 ACADEMIC RESEARCH LABORATORIES
             10.3.1 INCREASING RESEARCH FUNDING FOR PRECISION MEDICINE TO SUPPORT MARKET GROWTH
                    TABLE 83 PROTEOMICS MARKET FOR ACADEMIC RESEARCH LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)
     10.4 HOSPITALS
             10.4.1 RISING ADOPTION OF PROTEOMICS FOR DISEASE DIAGNOSIS TO DRIVE MARKET GROWTH
                    TABLE 84 PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY, 2019–2026 (USD MILLION)
     10.5 CLINICAL LABORATORIES
             10.5.1 INCREASING OUTSOURCING OF DIAGNOSTICS TESTS BY HOSPITALS IS SUPPORTING THE GROWTH OF THIS END-USER SEGMENT
                    TABLE 85 PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)
     10.6 OTHER END USERS
          TABLE 86 PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)

11 PROTEOMICS MARKET, BY REGION (Page No. - 163)
     11.1 INTRODUCTION
          TABLE 87 PROTEOMICS MARKET, BY REGION, 2019–2026 (USD MILLION)
     11.2 NORTH AMERICA
          FIGURE 27 NORTH AMERICA: PROTEOMICS MARKET SNAPSHOT
          TABLE 88 NORTH AMERICA: PROTEOMICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
          TABLE 89 NORTH AMERICA: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
          TABLE 90 NORTH AMERICA: PROTEOMICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
          TABLE 91 NORTH AMERICA: PROTEOMICS MARKET, BY END USER, 2019–2026 (USD MILLION)
             11.2.1 US
                        11.2.1.1 The US dominates the North American proteomics market
                                 TABLE 92 US: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 93 US: PROTEOMICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                 TABLE 94 US: PROTEOMICS MARKET, BY END USER, 2019–2026 (USD MILLION)
             11.2.2 CANADA
                        11.2.2.1 Strong infrastructure and availability of funding for biomedical research will support market growth
                                 TABLE 95 CANADA: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 96 CANADA: PROTEOMICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                 TABLE 97 CANADA: PROTEOMICS MARKET, BY END USER, 2019–2026 (USD MILLION)
     11.3 EUROPE
          TABLE 98 EUROPE: PROTEOMICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
          TABLE 99 EUROPE: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
          TABLE 100 EUROPE: PROTEOMICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
          TABLE 101 EUROPE: PROTEOMICS MARKET, BY END USER, 2019–2026 (USD MILLION)
             11.3.1 GERMANY
                        11.3.1.1 Germany is the largest market for proteomics in Europe
                                 TABLE 102 GERMANY: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 103 GERMANY: PROTEOMICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                 TABLE 104 GERMANY: PROTEOMICS MARKET, BY END USER, 2019–2026 (USD MILLION)
             11.3.2 UK
                        11.3.2.1 The UK has seen a surge in the prevalence of cancer
                                 TABLE 105 UK: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 106 UK: PROTEOMICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                 TABLE 107 UK: PROTEOMICS MARKET, BY END USER, 2019–2026 (USD MILLION)
             11.3.3 FRANCE
                        11.3.3.1 Proteomics research in France is strongly supported by the government
                                 TABLE 108 FRANCE: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 109 FRANCE: PROTEOMICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                 TABLE 110 FRANCE: PROTEOMICS MARKET, BY END USER, 2019–2026 (USD MILLION)
             11.3.4 SWITZERLAND
                        11.3.4.1 Market growth is primarily driven by the well-established pharmaceutical & biotechnology industry in the country
                                 TABLE 111 SWITZERLAND: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 112 SWITZERLAND: PROTEOMICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                 TABLE 113 SWITZERLAND: PROTEOMICS MARKET, BY END USER, 2019–2026 (USD MILLION)
             11.3.5 ITALY
                        11.3.5.1 Growth in this market is mainly driven by increasing life science R&D
                                 TABLE 114 ITALY: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 115 ITALY: PROTEOMICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                 TABLE 116 ITALY: PROTEOMICS MARKET, BY END USER, 2019–2026 (USD MILLION)
             11.3.6 SPAIN
                        11.3.6.1 Spain has a well-established network of research centers, universities, and hospitals
                                 TABLE 117 SPAIN: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 118 SPAIN: PROTEOMICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                 TABLE 119 SPAIN: PROTEOMICS MARKET, BY END USER, 2019–2026 (USD MILLION)
             11.3.7 REST OF EUROPE
                    TABLE 120 ROE: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                    TABLE 121 ROE: PROTEOMICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 122 ROE: PROTEOMICS MARKET, BY END USER, 2019–2026 (USD MILLION)
     11.4 ASIA PACIFIC
          FIGURE 28 ASIA PACIFIC: PROTEOMICS MARKET SNAPSHOT
          TABLE 123 APAC: PROTEOMICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
          TABLE 124 APAC: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
          TABLE 125 APAC: PROTEOMICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
          TABLE 126 APAC: PROTEOMICS MARKET, BY END USER, 2019–2026 (USD MILLION)
             11.4.1 CHINA
                        11.4.1.1 China is the fastest-growing market for proteomics
                                 TABLE 127 CHINA: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 128 CHINA: PROTEOMICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                 TABLE 129 CHINA: PROTEOMICS MARKET, BY END USER, 2019–2026 (USD MILLION)
             11.4.2 JAPAN
                        11.4.2.1 Large number of research initiatives towards the development of precision medicine is driving market growth
                                 TABLE 130 JAPAN: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 131 JAPAN: PROTEOMICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                 TABLE 132 JAPAN: PROTEOMICS MARKET, BY END USER, 2019–2026 (USD MILLION)
             11.4.3 INDIA
                        11.4.3.1 Large number of proteomics and genomics research studies undertaken in the country to support market growth
                                 TABLE 133 INDIA: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 134 INDIA: PROTEOMICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                 TABLE 135 INDIA: PROTEOMICS MARKET, BY END USER, 2019–2026 (USD MILLION)
             11.4.4 AUSTRALIA
                        11.4.4.1 Increasing focus of the healthcare system on precision medicine to offer significant growth opportunities
                                 TABLE 136 AUSTRALIA: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 137 AUSTRALIA: PROTEOMICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                 TABLE 138 AUSTRALIA: PROTEOMICS MARKET, BY END USER, 2019–2026 (USD MILLION)
             11.4.5 REST OF ASIA PACIFIC
                    TABLE 139 ROAPAC: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                    TABLE 140 ROAPAC: PROTEOMICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 141 ROAPAC: PROTEOMICS MARKET, BY END USER, 2019–2026 (USD MILLION)
     11.5 LATIN AMERICA
          TABLE 142 LATIN AMERICA: PROTEOMICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
          TABLE 143 LATIN AMERICA: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
          TABLE 144 LATIN AMERICA: PROTEOMICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
          TABLE 145 LATIN AMERICA: PROTEOMICS MARKET, BY END USER, 2019–2026 (USD MILLION)
             11.5.1 BRAZIL
                        11.5.1.1 Growing contract research and manufacturing activities in the country to support market growth
                                 TABLE 146 BRAZIL: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 147 BRAZIL: PROTEOMICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                 TABLE 148 BRAZIL: PROTEOMICS MARKET, BY END USER, 2019–2026 (USD MILLION)
             11.5.2 MEXICO
                        11.5.2.1 Strong pharmaceutical industry in the country to provide significant growth opportunities
                                 TABLE 149 MEXICO: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                 TABLE 150 MEXICO: PROTEOMICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                 TABLE 151 MEXICO: PROTEOMICS MARKET, BY END USER, 2019–2026 (USD MILLION)
             11.5.3 REST OF LATIN AMERICA
                    TABLE 152 ROLATAM: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                    TABLE 153 ROLATAM: PROTEOMICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 154 ROLATAM: PROTEOMICS MARKET, BY END USER, 2019–2026 (USD MILLION)
     11.6 MIDDLE EAST & AFRICA
             11.6.1 INCREASING PARTNERSHIPS AMONG GLOBAL PLAYERS WITH GOVERNMENT ORGANIZATIONS IN THE REGION TO SUPPORT MARKET GROWTH
                    TABLE 155 MEA: PROTEOMICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                    TABLE 156 MEA: PROTEOMICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 157 MEA: PROTEOMICS MARKET, BY END USER, 2019–2026 (USD MILLION)

12 COMPETITIVE LANDSCAPE (Page No. - 204)
     12.1 OVERVIEW
          FIGURE 29 KEY DEVELOPMENTS IN THE PROTEOMICS MARKET, JANUARY 2018–JANUARY 2021
     12.2 MARKET SHARE ANALYSIS
          FIGURE 30 PROTEOMICS MARKET SHARE, BY KEY PLAYER, 2019
     12.3 COMPANY EVALUATION QUADRANT
             12.3.1 DEFINITION AND METHODOLOGY
             12.3.2 VENDOR DIVE OVERVIEW
                        12.3.2.1 Stars
                        12.3.2.2 Emerging leaders
                        12.3.2.3 Pervasive players
                        12.3.2.4 Participants
                                 FIGURE 31 PROTEOMICS MARKET: COMPETITIVE LEADERSHIP MAPPING (2019)
     12.4 COMPANY EVALUATION MATRIX FOR STARTUPS (2019)
             12.4.1 PROGRESSIVE COMPANIES
             12.4.2 RESPONSIVE COMPANIES
             12.4.3 STARTING BLOCKS
             12.4.4 DYNAMIC COMPANIES
                    FIGURE 32 PROTEOMICS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS, 2019
     12.5 COMPETITIVE SCENARIO
          FIGURE 33 MARKET EVALUATION FRAMEWORK, JANUARY 2018– JANUARY 2021
             12.5.1 PRODUCT LAUNCHES
                    TABLE 158 PRODUCT LAUNCHES, JANUARY 2018–JANUARY 2021
             12.5.2 EXPANSIONS
                    TABLE 159 EXPANSIONS, JANUARY 2018–JANUARY 2021
             12.5.3 ACQUISITIONS
                    TABLE 160 ACQUISITIONS, JANUARY 2018–JANUARY 2021
             12.5.4 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
                    TABLE 161 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, JANUARY 2018–JANUARY 2021

13 COMPANY PROFILES (Page No. - 213)
(Business overview, Products offered, Recent developments, MNM view)*
     13.1 KEY PLAYERS
             13.1.1 THERMO FISHER SCIENTIFIC, INC.
                    FIGURE 34 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2019)
             13.1.2 AGILENT TECHNOLOGIES, INC.
                    FIGURE 35 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2019)
             13.1.3 MERCK KGAA
                    FIGURE 36 MERCK KGAA: COMPANY SNAPSHOT (2019)
             13.1.4 DANAHER CORPORATION
                    FIGURE 37 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
             13.1.5 WATERS CORPORATION
                    FIGURE 38 WATERS CORPORATION: COMPANY SNAPSHOT (2019)
             13.1.6 BIO-RAD LABORATORIES, INC.
                    FIGURE 39 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2019)
             13.1.7 BRUKER CORPORATION
                    FIGURE 40 BRUKER CORPORATION: COMPANY SNAPSHOT (2019)
             13.1.8 GE HEALTHCARE
                    FIGURE 41 GE HEALTHCARE: COMPANY SNAPSHOT (2019)
             13.1.9 PERKINELMER, INC.
                    FIGURE 42 PERKINELMER: COMPANY SNAPSHOT (2019)
             13.1.10 LUMINEX CORPORATION
                     FIGURE 43 LUMINEX CORPORATION: COMPANY SNAPSHOT (2019)
             13.1.11 EUROFINS SCIENTIFIC
                     FIGURE 44 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019)
             13.1.12 HORIBA, LTD.
                     FIGURE 45 HORIBA, LTD.: COMPANY SNAPSHOT (2019)
             13.1.13 ILLUMINA, INC.
                     FIGURE 46 ILLUMINA, INC.: COMPANY SNAPSHOT (2019)
             13.1.14 QIAGEN N.V.
                     FIGURE 47 QIAGEN N.V.: COMPANY SNAPSHOT (2019)
     13.2 OTHER PLAYERS
             13.2.1 CREATIVE PROTEOMICS
             13.2.2 PROMEGA CORPORATION
             13.2.3 SENGENICS
             13.2.4 BIOMAX INFORMATICS AG
             13.2.5 MS BIOWORKS, LLC
             13.2.6 WUXI NEXTCODE
             13.2.7 FIOS GENOMICS, LTD.
             13.2.8 GENEWIZ
             13.2.9 BIOGNOSYS AG
             13.2.10 BIOPROXIMITY
             13.2.11 MRM PROTEOMICS INC.
             13.2.12 INTEGRATED PROTEOMICS APPLICATIONS
             13.2.13 POOCHON SCIENTIFIC LLC
             13.2.14 PROTEOME FACTORY AG
             13.2.15 VPROTEOMICS
             13.2.16 APPLIED BIOMICS INC.

*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.

14 APPENDIX (Page No. - 285)
     14.1 INSIGHTS OF INDUSTRY EXPERTS
     14.2 ADDITIONAL INSIGHTS
             14.2.1 MASS SPECTROMETRY
             14.2.2 QUANTITATIVE PROTEOMICS
             14.2.3 TARGETED PROTEOMICS
     14.3 DISCUSSION GUIDE
     14.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     14.5 AVAILABLE CUSTOMIZATIONS
     14.6 RELATED REPORTS
     14.7 AUTHOR DETAILS

This study involved four major activities in estimating the current size of the proteomics market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments' market size.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative and quantitative information and assess future prospects.

The following is a breakdown of the primary respondents:

Proteomics Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the proteomics market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry have been identified through extensive secondary research
  • The revenues generated by leading players operating in the proteomics market have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Proteomics Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, segment, and forecast the global proteomics market by instrumentation technology, reagent, service and software, application, end user, and region
  • To provide detailed information about the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the proteomics market with respect to five main regions (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) along with their respective key countries
  • To profile the key players in the global proteomics market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, partnerships, agreements, joint ventures, and R&D activities of the leading players in the proteomics market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Country Information

  • Proteomics market size and growth rate estimates for counties in Rest of Europe, the Rest of Asia Pacific and Rest of the World

Company profiles

  • Additional five company profiles of players operating in the proteomics market
COVID-19

Get in-depth analysis of the COVID-19 impact on the Proteomics Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Proteomics Market

Request For Special Pricing
Report Code
BT 2341
Published ON
Mar, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Proteomics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home